RK

Rahul Kumar

Active Director Director DIN 10050731
DIN 10050731 First appointment Feb 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2023
Shareholding value •••• Premium profile

About Rahul Kumar

Data last updated:

Rahul Kumar is a Director at Biosense Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Biosense Pharmaceuticals Private Limited reported revenue of ₹2.1 Lakh (FY 2024).

DIN 10050731
Primary Designation Director
Industry Pharma
First Appointment 20 Feb 2023
Oldest Company Age 3 yrs
Largest company Biosense Pharmaceuticals Private Limited · ₹2.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Feb 20232023₹2.1 Lakh (FY 2024)Active

Board colleagues of Rahul Kumar

Directorship timeline

Open interactive timeline →
Biosense Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rahul Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Kumar

Rahul Kumar currently holds 1 directorship: Biosense Pharmaceuticals Private Limited (Director, since 20 Feb 2023, revenue ₹2.1 Lakh (FY 2024)).

Rahul Kumar was first appointed on 20 Feb 2023 as Director at Biosense Pharmaceuticals Private Limited.

The current boards of Rahul Kumar's companies include Pankaj Kumar Singh (Biosense Pharmaceuticals Private Limited), Ringku Kumari (Biosense Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available